# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-22-283649
Filing Date
2022-11-14
Accepted
2022-11-14 07:06:10
Documents
42
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d411392d8k.htm iXBRL | 8-K | 24554
2 | EX-99.1 | d411392dex991.htm | EX-99.1 | 35942
3 | EX-99.2 | d411392dex992.htm | EX-99.2 | 21441
7 | GRAPHIC | g411392ex99_2p10g1.jpg | GRAPHIC | 178020
8 | GRAPHIC | g411392ex99_2p11g1.jpg | GRAPHIC | 230515
9 | GRAPHIC | g411392ex99_2p12g1.jpg | GRAPHIC | 185545
10 | GRAPHIC | g411392ex99_2p13g1.jpg | GRAPHIC | 180864
11 | GRAPHIC | g411392ex99_2p14g1.jpg | GRAPHIC | 218894
12 | GRAPHIC | g411392ex99_2p15g1.jpg | GRAPHIC | 174758
13 | GRAPHIC | g411392ex99_2p16g1.jpg | GRAPHIC | 214408
14 | GRAPHIC | g411392ex99_2p17g1.jpg | GRAPHIC | 170664
15 | GRAPHIC | g411392ex99_2p18g1.jpg | GRAPHIC | 163827
16 | GRAPHIC | g411392ex99_2p19g1.jpg | GRAPHIC | 206828
17 | GRAPHIC | g411392ex99_2p1g1.jpg | GRAPHIC | 182501
18 | GRAPHIC | g411392ex99_2p20g1.jpg | GRAPHIC | 162754
19 | GRAPHIC | g411392ex99_2p21g1.jpg | GRAPHIC | 172138
20 | GRAPHIC | g411392ex99_2p22g1.jpg | GRAPHIC | 177803
21 | GRAPHIC | g411392ex99_2p23g1.jpg | GRAPHIC | 227505
22 | GRAPHIC | g411392ex99_2p24g1.jpg | GRAPHIC | 165162
23 | GRAPHIC | g411392ex99_2p25g1.jpg | GRAPHIC | 249867
24 | GRAPHIC | g411392ex99_2p26g1.jpg | GRAPHIC | 174639
25 | GRAPHIC | g411392ex99_2p27g1.jpg | GRAPHIC | 187582
26 | GRAPHIC | g411392ex99_2p2g1.jpg | GRAPHIC | 315139
27 | GRAPHIC | g411392ex99_2p3g1.jpg | GRAPHIC | 106966
28 | GRAPHIC | g411392ex99_2p4g1.jpg | GRAPHIC | 206381
29 | GRAPHIC | g411392ex99_2p5g1.jpg | GRAPHIC | 176143
30 | GRAPHIC | g411392ex99_2p6g1.jpg | GRAPHIC | 164880
31 | GRAPHIC | g411392ex99_2p7g1.jpg | GRAPHIC | 212428
32 | GRAPHIC | g411392ex99_2p8g1.jpg | GRAPHIC | 175938
33 | GRAPHIC | g411392ex99_2p9g1.jpg | GRAPHIC | 269389
34 | GRAPHIC | g411392new.jpg | GRAPHIC | 11548
| Complete submission text file | 0001193125-22-283649.txt |  | 7468375

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | tcrt-20221114.xsd | EX-101.SCH | 2846
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tcrt-20221114_lab.xml | EX-101.LAB | 17237
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tcrt-20221114_pre.xml | EX-101.PRE | 10806
36 | EXTRACTED XBRL INSTANCE DOCUMENT | d411392d8k_htm.xml | XML | 3229

Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 221380113
SIC: 2834 Pharmaceutical Preparations